{"id":468564,"date":"2022-06-29T00:03:00","date_gmt":"2022-06-28T21:03:00","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/fda-advisers-say-the-u-s-needs-updated-covid-19-boosters-to-fight-omicron\/"},"modified":"2022-06-29T00:03:00","modified_gmt":"2022-06-28T21:03:00","slug":"fda-advisers-say-the-u-s-needs-updated-covid-19-boosters-to-fight-omicron","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/fda-advisers-say-the-u-s-needs-updated-covid-19-boosters-to-fight-omicron\/","title":{"rendered":"#: FDA advisers say the U.S. needs updated COVID-19 boosters to fight omicron"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a407e372b298\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #dd3333;color:#dd3333\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #dd3333;color:#dd3333\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a407e372b298\" checked aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/buradabiliyorum.com\/en\/fda-advisers-say-the-u-s-needs-updated-covid-19-boosters-to-fight-omicron\/#%E2%80%9C_FDA_advisers_say_the_US_needs_updated_COVID-19_boosters_to_fight_omicron%E2%80%9D\" >&#8220;: FDA advisers say the U.S. needs updated COVID-19 boosters to fight omicron&#8221;<\/a><ul class='ez-toc-list-level-2' ><li class='ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/buradabiliyorum.com\/en\/fda-advisers-say-the-u-s-needs-updated-covid-19-boosters-to-fight-omicron\/#COVID-19_booster_strategy_should_focus_on_developing_new_shots_that_better_protect_against_omicron_and_its_subvariants\" >COVID-19 booster strategy should focus on developing new shots that better protect against omicron and its subvariants<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/buradabiliyorum.com\/en\/fda-advisers-say-the-u-s-needs-updated-covid-19-boosters-to-fight-omicron\/#Jaimy_Lee\" >Jaimy Lee<\/a><\/li><\/ul><\/li><\/ul><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h1><span class=\"ez-toc-section\" id=\"%E2%80%9C_FDA_advisers_say_the_US_needs_updated_COVID-19_boosters_to_fight_omicron%E2%80%9D\"><\/span>&#8220;: FDA advisers say the U.S. needs updated COVID-19 boosters to fight omicron&#8221;<span class=\"ez-toc-section-end\"><\/span><\/h1>\n<h2 class=\"article__subhead\" itemprop=\"alternativeHeadline\"><span class=\"ez-toc-section\" id=\"COVID-19_booster_strategy_should_focus_on_developing_new_shots_that_better_protect_against_omicron_and_its_subvariants\"><\/span>\n  COVID-19 booster strategy should focus on developing new shots that better protect against omicron and its subvariants<br \/>\n<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><\/p>\n<div class=\"column column--full article__content\">\n<div class=\"article__side\">\n<div class=\"container--sticky not-active\">\n<div id=\"cx-next\" data-nosnippet>\n              <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div id=\"js-article__body\" class=\"article__body article-wrap at16-col16 barrons-article-wrap\" itemprop=\"articleBody\" data-sbid=\"WP-MKTW-0000986118\" role=\"document\">\n<div class=\"barrons-article-ad-wrapper\">\n<div data-track=\"barrons-article-ad-wrap\" class=\"barrons-article-ad sticky_item\">\n<div class=\"barrons-main-article-ad-target sticky_target body_ad\" aria-hidden=\"true\"><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div data-layout=\"\n                inline\" data-layout-mobile=\"\" class=\"\n          media-object\n          type-InsetArticleReader\n              \n              inline\n  article__inset\n          article__inset--type-InsetArticleReader\n              article__inset--inline\n  \"><\/p>\n<div class=\"media-object-article-reader\">\n<div class=\"audioplayer\" data-sbid=\"WP-MKTW-0000986118\" role=\"region\" aria-label=\"Listen to Article\" tabindex=\"-1\" id=\"articlereader\" data-show-title=\"false\" data-theme=\"wsj-article-reader\" data-show-header=\"false\" data-show-subscribe=\"false\" data-ads-enabled=\"true\" data-save-publication=\"false\">\n        <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<p>       The U.S. should pursue a COVID-19 booster strategy that focuses on developing new shots that better protect against omicron and its subvariants, according to a recommendation from a Food and Drug Administration advisory committee.<\/p>\n<p> The group of independent medical experts on Tuesday voted 19-2 that the COVID-19 boosters should include omicron and its subvariants. <\/p>\n<div class=\"paywall\">\n<p>They did not decide whether a bivalent vaccine, which is designed to equally protect against the original strain of the virus and omicron, or a monovalent shot, which would comprise only one strain, will be used going forward. <\/p>\n<p>COVID-19 vaccines like Moderna\u2019s<br \/>\n        MRNA,<br \/>\n        <bg-quote field=\"percentchange\" format=\"0,000.00%\" channel=\"\/zigman2\/quotes\/205619834\/composite\" class=\"negative\">-2.18%<\/bg-quote><br \/>\n       Spikevax and BioNTech<br \/>\n        BNTX,<br \/>\n        <bg-quote field=\"percentchange\" format=\"0,000.00%\" channel=\"\/zigman2\/quotes\/214419716\/composite\" class=\"negative\">-2.71%<\/bg-quote><br \/>\n       and Pfizer\u2019s<br \/>\n        PFE,<br \/>\n        <bg-quote field=\"percentchange\" format=\"0,000.00%\" channel=\"\/zigman2\/quotes\/202877789\/composite\" class=\"negative\">-2.35%<\/bg-quote><br \/>\n       Comirnaty are based on the original strain of the virus, which was first detected in 2019 in Wuhan, China. The currently available boosters also rely on the same ancestral strain of SARS-CoV-2.\u00a0<\/p>\n<p>However, the emergence and staying power of omicron has raised questions about whether a new generation of COVID-19 vaccines is necessary. Already this year, the U.S. has watched the rise and fall of omicron subvariants like BA.1, which is no longer circulating, and BA.4 or BA.5, which made up <a rel=\"nofollow noopener\" target=\"_blank\" href=\"https:\/\/covid.cdc.gov\/covid-data-tracker\/#variant-proportions\" class=\"icon none\">more than half of all U.S. cases<\/a> last week.\u00a0<\/p>\n<p>\u201cAlthough it\u2019s been pointed out that the current omicron-related strains are less severe in <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/general\/\" data-internallinksmanager029f6b8e52c=\"3\" title=\"General\" target=\"_blank\" rel=\"noopener\">general<\/a>, even a less severe strain, if it\u2019s more transmissible, can lead to more deaths because of the sheer number of people who get infected,\u201d Dr. Mark Sawyer, an infectious-disease physician at Rady Children\u2019s Hospital in La Jolla, said Tuesday during the meeting. \u201cSo I think given that state of evolution, we\u2019re going to be behind the eight ball if we wait longer.\u201d<\/p>\n<p>The day\u2019s discussion at the all-day meeting also highlighted the challenge of guessing what a virus that has evaded predictions will do next, particularly for regulators and vaccine makers. <\/p>\n<p>\u201cNone of us has a crystal ball,\u201d Marks said, \u201cand we are trying to use every last ounce from predictive modeling and from the data that we have to try to get ahead of a virus.\u201d<\/p>\n<p>Marks described the vote as \u201c<a href=\"https:\/\/buradabiliyorum.com\/en\/category\/sciencee\/\" data-internallinksmanager029f6b8e52c=\"5\" title=\"Science\" target=\"_blank\" rel=\"noopener\">science<\/a> at its hardest\u201d because it requires medical experts to predict what variants will be circulating six months from now, a notably delicate issue given omicron\u2019s walloping arrival in the weeks that overl<a href=\"https:\/\/buradabiliyorum.com\/en\/category\/download-scripts-themes-apps\/\" data-internallinksmanager029f6b8e52c=\"9\" title=\"Download Scripts &amp; Themes &amp; Apps\" target=\"_blank\" rel=\"noopener\">app<\/a>ed with the winter holidays last year. Millions of Americans tested positive for the virus back in December and January.\u00a0\u00a0<\/p>\n<p>\u201cI don\u2019t know what the variant of the day is going to be when we get to the end of the year or next year what we might want to be able to be prepared for,\u201d the National Institutes of Health\u2019s Adam Berger said. \u201cAnd so answering the question at this time \u2014 I\u2019m not sure that we have evidence to support a change necessarily today.\u201d<\/p>\n<div id=\"cx-membership-tile\"><\/div>\n<p>Several committee members requested additional data from vaccine makers about the new COVID-19 booster studies that they are conducting. <\/p>\n<p>This means a new generation of COVID-19 boosters could be ready to be rolled out as soon as late summer or early fall, depending on the composition of the vaccine and the authorization process. Dr. Peter Marks, the director of the FDA\u2019s Center for Biologics Evaluation and Research, said Americans could start receiving the new boosters as soon as early October.\u00a0<\/p>\n<p><strong>Here\u2019s\u00a0what we know so far about the COVID-19 boosters in development<\/strong><\/p>\n<p>The decision sets the stage for how vaccine makers move forward with their plans to develop new vaccines.\u00a0<\/p>\n<ul class=\"articleList\">\n<li>\n      Moderna had said it plans to complete its regulatory submission to the FDA for a bivalent vaccine within the next two weeks. \u201cPending authorization, large-scale supply of a bivalent omicron-containing vaccine could be available in late July and early August,\u201d Stephen Hoge, Moderna\u2019s president, told the committee on Tuesday. If a BA.4 or BA.5 strain was selected, it would likely mean that shot would be available in October. \u00a0<\/p>\n<\/li>\n<\/ul>\n<ul class=\"articleList\">\n<li>\n      Pfizer proposed a different idea. BioNTech and Pfizer tested monovalent and bivalent versions of their vaccine, finding that a monovalent omicron-based vaccine produced higher neutralizing antibody titers one month after administration, compared with their bivalent booster candidate that included omicron. \u201cWe propose that an EUA be considered for an omicron BA.1 modified vaccine to formally establish the pathway for variant modified vaccines that would allow vaccine manufacturers in the future to provide variant modified vaccines quickly,\u201d said Dr. Kena Swanson, Pfizer\u2019s VP of viral vaccines.\u00a0 A BA.4 or BA.5 vaccine could be ready by early October, executives said. <\/p>\n<\/li>\n<\/ul>\n<ul class=\"articleList\">\n<li>\n      Novavax<br \/>\n        NVAX,<br \/>\n        <bg-quote field=\"percentchange\" format=\"0,000.00%\" channel=\"\/zigman2\/quotes\/202614340\/composite\" class=\"negative\">-5.13%<\/bg-quote><br \/>\n       also presented clinical data about how its recombinant protein-based COVID-19 vaccine candidate has performed against omicron even though the primary <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/watch-movies-tv-seriess\/\" data-internallinksmanager029f6b8e52c=\"8\" title=\"Watch Movies &amp; TV Series\" target=\"_blank\" rel=\"noopener\">series<\/a> of shots remains under review at the FDA. The company told the committee it could have doses of a BA.4 vaccine ready in the fourth quarter.\u00a0<\/p>\n<\/li>\n<\/ul>\n<ul class=\"articleList\">\n<li>\n      Johnson &amp; Johnson<br \/>\n        JNJ,<br \/>\n        <bg-quote field=\"percentchange\" format=\"0,000.00%\" channel=\"\/zigman2\/quotes\/201724570\/composite\" class=\"negative\">-2.84%<\/bg-quote><br \/>\n       did not present data at Tuesday\u2019s meeting. A company spokesperson told MarketWatch that the company does not plan to update its COVID-19 vaccine. \u201cThe company will focus on supplying its COVID-19 vaccine in parts of the world where the pandemic remains an emergency and there is acute need,\u201d a J&amp;J spokesperson said Tuesday.\u00a0<\/p>\n<\/li>\n<\/ul><\/div>\n<\/div><\/div>\n<p><\/p>\n<div class=\"byline article__byline\">\n<p>    <span>By<\/span><\/p>\n<div class=\"author mobile-scrim hasMenu\" data-scrim='{\"type\":\"author\",\"header\":\"Jaimy Lee\",\"subhead\":\"The Wall Street Journal\",\"list\":[{\"type\":\"link\",\"icon\":\"bio\",\"url\":\"https:\/\/www.marketwatch.com\/topics\/journalists\/jaimy-lee\",\"text\":\"Biography\"},{\"type\":\"link\",\"icon\":\"twitter\",\"url\":\"https:\/\/twitter.com\/jaimy_lee\",\"text\":\"@jaimy_lee\"}]}' itemscope itemprop=\"author\" itemtype=\"http:\/\/schema.org\/Person\">\n<h4 itemprop=\"name\"><span class=\"ez-toc-section\" id=\"Jaimy_Lee\"><\/span>Jaimy Lee<span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p><ufc-follow-author-widget product=\"marketwatch\" author-id=\"76_MW\" author-name=\"Jaimy Lee\" signin-url=\"https:\/\/accounts.marketwatch.com\/login?target=https%3A%2F%2Fwww.marketwatch.com%2Fstory%2Ffda-advisors-say-the-u-s-needs-updated-covid-19-boosters-11656450114%3Frss%3D1%26siteid%3Drss\" panda-api=\"https:\/\/follow-api.marketwatch.com\"><\/ufc-follow-author-widget><\/p><\/div>\n<\/div>\n<p><script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><\/p>\n<blockquote><p><strong><span style=\"color: #ff6600;\">If you liked the article, do not forget to share it with your friends. Follow us on\u00a0<span style=\"color: #ff0000;\"><a style=\"color: #ff0000;\" href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMLG0nwswvr63Aw\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Google News<\/a><\/span>\u00a0too, click on the star and choose us from your favorites.<\/span><\/strong><\/p><\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\">For forums sites go to <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/forum.buradabiliyorum.com\/\" target=\"_blank\" rel=\"noopener\">Forum.BuradaBiliyorum.Com<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<blockquote>\n<p style=\"text-align: center;\"><strong>If you want to read more <a href=\"https:\/\/buradabiliyorum.com\/en\/category\/news\/\" data-internallinksmanager029f6b8e52c=\"2\" title=\"News\" target=\"_blank\" rel=\"noopener\">News<\/a> articles, you can visit our <span style=\"color: #ff9900;\"><a style=\"color: #ff9900;\" href=\"https:\/\/en.buradabiliyorum.com\/news\/\" target=\"_blank\" rel=\"noopener\">News category.<\/a><\/span><\/strong><\/p>\n<\/blockquote>\n<p><span style=\"color: black;\"><a style=\"color: #ff9900;\" href=\"http:\/\/www.marketwatch.com\/news\/story.asp?guid=%7B20C05575-04D4-B545-7F0C-06220A19F6FE%7D&#038;siteid=rss&#038;rss=1\" target=\"_blank\" rel=\"noopener\">Source<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;: FDA advisers say the U.S. needs updated COVID-19 boosters to fight omicron&#8221; COVID-19 booster strategy should focus on developing new shots that better protect against omicron and its subvariants The U.S. should pursue a COVID-19 booster strategy that focuses on developing new shots that better protect against omicron and its subvariants, according to a&#8230;<\/p>\n","protected":false},"author":1,"featured_media":468565,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"https:\/\/images.mktw.net\/im-572892\/social","fifu_image_alt":"","footnotes":""},"categories":[70897],"tags":[],"class_list":["post-468564","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/468564","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/comments?post=468564"}],"version-history":[{"count":0,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/posts\/468564\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media\/468565"}],"wp:attachment":[{"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/media?parent=468564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/categories?post=468564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buradabiliyorum.com\/en\/wp-json\/wp\/v2\/tags?post=468564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}